MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 77 filers reported holding MERSANA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,700 | -58.0% | 52,520 | +8.7% | 0.00% | -100.0% |
| Q2 2023 | $158,900 | -13.5% | 48,298 | +8.1% | 0.00% | 0.0% |
| Q1 2023 | $183,594 | -28.4% | 44,670 | +2.0% | 0.00% | -50.0% |
| Q4 2022 | $256,557 | -11.2% | 43,781 | +2.3% | 0.00% | 0.0% |
| Q3 2022 | $289,000 | +52.9% | 42,793 | +4.3% | 0.00% | +100.0% |
| Q2 2022 | $189,000 | +33.1% | 41,017 | +15.4% | 0.00% | 0.0% |
| Q1 2022 | $142,000 | -40.1% | 35,533 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $237,000 | -35.8% | 38,034 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $369,000 | -29.6% | 39,172 | +1.5% | 0.00% | 0.0% |
| Q2 2021 | $524,000 | +4.4% | 38,588 | +24.4% | 0.00% | 0.0% |
| Q1 2021 | $502,000 | -39.0% | 31,025 | +0.3% | 0.00% | -33.3% |
| Q4 2020 | $823,000 | +38.8% | 30,944 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $593,000 | -9.6% | 31,832 | +13.5% | 0.00% | 0.0% |
| Q2 2020 | $656,000 | +429.0% | 28,051 | +31.9% | 0.00% | +200.0% |
| Q1 2020 | $124,000 | -3.9% | 21,260 | -5.5% | 0.00% | – |
| Q4 2019 | $129,000 | +258.3% | 22,488 | -0.8% | 0.00% | – |
| Q3 2019 | $36,000 | -60.9% | 22,677 | -0.7% | 0.00% | – |
| Q2 2019 | $92,000 | +119.0% | 22,837 | +184.4% | 0.00% | – |
| Q1 2019 | $42,000 | +23.5% | 8,030 | -3.1% | 0.00% | – |
| Q4 2018 | $34,000 | -59.5% | 8,291 | -0.8% | 0.00% | – |
| Q3 2018 | $84,000 | -42.1% | 8,354 | +3.0% | 0.00% | -100.0% |
| Q2 2018 | $145,000 | +28.3% | 8,113 | +13.5% | 0.00% | – |
| Q1 2018 | $113,000 | +101.8% | 7,151 | +110.1% | 0.00% | – |
| Q4 2017 | $56,000 | 0.0% | 3,404 | +5.4% | 0.00% | – |
| Q3 2017 | $56,000 | – | 3,231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |